Alkaline Water Improves Quality of Life in IBS Patients
- Authors
- Dong Woo Shin, Hyuk Yoon, Hyun Soo Kim, Yoon Jin Choi, Cheol Min Shin, Young Soo Park, Nayoung Kim, Dong Ho Lee
- Journal
- Evidence-Based Complementary and Alternative Medicine
- Year
- 2018
- DOI
- 10.1155/2018/9147914
- Study Type
- Human
- Outcome
- Positive
- Peer Reviewed
- Yes
- Country
- South Korea
- Health Condition
- Irritable Bowel Syndrome with Diarrhea (IBS-D)
- Body System
- Gastrointestinal
TL;DR
Drinking alkaline-reduced water (ARW) for eight weeks can make people with a certain type of irritable bowel syndrome (IBS) feel better overall.
Key Finding
Patients drinking alkaline-reduced water for eight weeks showed significantly greater improvement in IBS-related quality-of-life scores compared to those drinking placebo water.
Summary
This small study tested whether alkaline-reduced water (water treated to be less acidic and contain more hydrogen) could help people with irritable bowel syndrome who experience diarrhea. Over eight weeks, 27 patients either drank at least 2 liters daily of alkaline-reduced water or placebo water. The alkaline-reduced water group showed greater improvement in quality-of-life scores related to their IBS symptoms compared to the placebo group, though abdominal pain improvements were similar between groups.
Practical Takeaway
This is a small pilot study (only 27 participants) suggesting alkaline-reduced water may help with IBS-related quality of life, though the improvement in actual abdominal pain was not significantly different from placebo. Larger studies would be needed to confirm whether this effect is real and meaningful for most people with diarrhea-predominant IBS.
Abstract
Objectives: The purpose of this study was to investigate whether the ingestion of alkaline-reduced water (ARW) is helpful in improving the symptoms of diarrhea-predominant irritable bowel syndrome (IBS). Methods: Twenty-seven patients (male, 25.9%; mean, 41.7 years old) with diarrhea-predominant IBS were randomly allocated to two groups. For eight weeks, the ARW group (n = 13) ingested at least 2 liters/day of ARW, while the control group (n = 14) ingested placebo water. IBS symptom scores (quality-of-life, abdominal pain/discomfort), stool form, and frequency were assessed before and after treatment via questionnaires. Results: Eight patients (61.5%) in the ARW group and six patients (42.9%) in the control group indicated that their symptoms had improved in more than four out of the eight weeks of treatment (p = 0.449). The IBS quality-of-life score significantly improved from 57.2 to 30.8 in the ARW group; this improvement was significantly greater than the slight improvement from 48.7 to 42.2 observed in the control group (p = 0.029). The abdominal pain score improved from 1.8 to 0.9 in the ARW group and from 1.8 to 1.1 in the control group, with no significant group difference (p = 0.232). Conclusions: Drinking ARW for eight weeks improves the quality of life in patients with diarrhea-predominant IBS.